Subscribe To
Revive therapeutics provides update of phase 3 clinical study for bucillamine in treatment of covid-19
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has announced an update on its US Food & Drug Administration (FDA) ...
March 20, 2023, 9:03 am
Karuna's stock is up after schizophrenia drugs meets primary endpoint in clinical trial
Shares of Karuna Therapeutics Inc. KRTX, +1.21% rallied about 14% in premarket trading on Monday after the company said its experimental treatment for...
March 20, 2023, 7:46 am
Enphase energy is still a buy for long-term growth investors
Despite continuing to deliver earnings and revenue that beat expectations, Enphase Energy, Inc. (NASDAQ...
March 20, 2023, 7:11 am
Deciphera pharmaceuticals: intrigue phase 3 shows substantial benefit
Deciphera has a strong portfolio of investigational kinase inhibitors, including ripretinib, vimseltinib, and DCC-3116, that have demonstrated encoura...
March 18, 2023, 5:21 am
5 investors betting big on enphase (enph) stock
Among the solar stocks that had previously been on a nice run through early March, Enphase Energy (NAS...
March 17, 2023, 2:58 pm
Merck's combination therapy in lung cancer fails a phase 2 clinical trial
Merck & Co. Inc. MRK, -0.27% said late Thursday that its combination therapy of vibostolimab and Keytruda did not outperform chemotherapy in a ...
March 17, 2023, 8:08 am
Why i bought more hudson technologies during the sell-off
Hudson operates in a regulated industry where the government has ruled a quick HFCs phase out. Hudson p...
March 16, 2023, 7:01 pm
Alpine immune sciences to present povetacicept (alpn-303) phase 1 (ruby-1) study data at the 2023 american academy of dermatology annual meeting
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc....
March 16, 2023, 5:30 pm
Edesa biotech to present favorable dermatitis drug results at american academy of dermatology association annual meeting
TORONTO, ON / ACCESSWIRE / March 16, 2023 / Edesa Biotech, Inc. announced today that the company has been selected to present clinical trial data from...
March 16, 2023, 4:10 pm
Ecb hikes by 50bp and drops forward guidance, while keeping the door open to more hikes
The ECB continues to fight against inflation and seems unperturbed by the market turmoil of the last few days. Dropping forward guidance, lowering inf...
March 16, 2023, 3:07 pm
Metal energy says final drill hole assays from manibridge project demonstrate robust nature of nickel system
Metal Energy Corp (TSX-V:MERG) has announced the final drill hole assays of the phase Two drill progr...
March 16, 2023, 10:26 am
Why is okyo pharma (okyo) stock up 13% today?
Okyo Pharma (NASDAQ: OKYO ) stock is on the rise Thursday as investors react to news about its phase 2 ...
March 16, 2023, 10:19 am
Japan gold kicks off drilling at barrick alliance mizobe project in southern kyushu
Japan Gold (TSX-V:JG) Corp has announced the start of drilling at the Barrick Alliance Mizobe Project in southern Kyushu, Japan, which is one of six p...
March 16, 2023, 9:57 am
Should you invest in europe etfs despite credit suisse crisis?
Europe investing has outperformed the United States in the initial phase of 2023. While the Credit Suis...
March 16, 2023, 9:10 am
3 stocks to buy with a dividend yield of over 5%
Equities have been going through a phase of uncertainty with a looming recession and aggressive contrac...
March 16, 2023, 9:09 am
Ardagh metal packaging: excessive dividend is on shaky ground
Ardagh Metal Packaging was created via a SPAC when its parent company, Ardagh Group, sold a ~20% stake for $3.4 billion in cash. AMBP initiated a 10c ...
March 16, 2023, 9:04 am
Cvrx reiterates plans to discuss the preliminary results from the post-market phase of the beat-hf trial at tht 2023 and schedules a conference call
MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturin...
March 16, 2023, 8:30 am
3m ‘hasn't done anything wrong' in combat arms earplugs case, cfo says
That's what 3M Co.'s CFO Monish Patolawala said at the J.P. Morgan Industrials Conference in New York, according to a transcript provided by AlphaSens...
March 15, 2023, 3:48 pm
Roivant stock pops after positive topline results for its vtama cream from the adoring 2 atopic dermatitis phase 3 trial
Roivant Sciences Limited saw its shares rise after its subsidiary Dermavant Sciences reported positive topline results from ADORING 2, one of two
March 15, 2023, 12:34 pm
Pacbio's (pacb) latest offering to enhance genome analysis
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy....
March 15, 2023, 12:14 pm